PREDICTION OF BACTERIAL SUSCEPTIBILITY TO CEFPODOXIME BY USING THE CEFTRIAXONE MINIMUM INHIBITORY CONCENTRATION RESULT

被引:11
作者
JONES, RN
ZURENKO, GE
机构
[1] UPJOHN CO,UPJOHN LABS,KALAMAZOO,MI 49001
[2] UNIV IOWA,COLL MED,IOWA CITY,IA
关键词
D O I
10.1016/0732-8893(93)90041-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The cross-resistance or cross-susceptibility of cefpodoxime and ceftriaxone for 3700 strains of Enterobacteriaceae, oxacillin-susceptible staphylococci, Streptococcus spp., Haemophilus influenzae, Moraxella catarrhalis, and Neisseria gonorrhoeae was evaluated. With the exception of tests with Enterobacter spp. and Morganella morganii, the ceftriaxone minimum inhibitory concentration (MIC) result interpretive criteria predicted bacterial susceptibility (or resistance) to cefpodoxime with an acceptable rate of serious interpretive errors (1.5%) and an absolute categorical agreement >92%. By using cefpodoxime interpretive criteria for ceftriaxone MICs, the interpretive errors for testing enteric bacilli were reduced from 2.2% to 1.5%.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 12 条
[1]   CEFUROXIME AND CEFUROXIME AXETIL VERSUS AMOXICILLIN PLUS CLAVULANIC ACID IN THE TREATMENT OF LOWER RESPIRATORY-TRACT INFECTIONS [J].
BRAMBILLA, C ;
KASTANAKIS, S ;
KNIGHT, S ;
CUNNINGHAM, K .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) :118-124
[2]   INVITRO ACTIVITY OF AN ORAL IMINOMETHOXY AMINOTHIAZOLYL CEPHALOSPORIN, R-3746 [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :671-677
[3]   INVITRO ACTIVITY OF U-76,252 (CS-807), A NEW ORAL CEPHALOSPORIN [J].
FASS, RJ ;
HELSEL, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (07) :1082-1085
[4]   STUDIES ON ORALLY ACTIVE CEPHALOSPORIN ESTERS [J].
FUJIMOTO, K ;
ISHIHARA, S ;
YANAGISAWA, H ;
IDE, J ;
NAKAYAMA, E ;
NAKAO, H ;
SUGAWARA, S ;
IWATA, M .
JOURNAL OF ANTIBIOTICS, 1987, 40 (03) :370-384
[5]  
GRIMM H, 1991, ZBL BAKT-INT J MED M, V276, P54
[7]   INVITRO EVALUATIONS OF U-76,252 (CS-807) - ANTIMICROBIAL SPECTRUM, BETA-LACTAMASE STABILITY, AND ENZYME-INHIBITION [J].
JONES, RN ;
BARRY, AL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (04) :245-249
[8]   CLINICAL AND ECONOMIC-EVALUATION OF ORAL CIPROFLOXACIN AFTER AN ABBREVIATED COURSE OF INTRAVENOUS ANTIBIOTICS [J].
PALADINO, JA ;
SPERRY, HE ;
BACKES, JM ;
GELBER, JA ;
SERRIANNE, DJ ;
CUMBO, TJ ;
SCHENTAG, JJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (05) :462-470
[9]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF CS-807, A NEW ORAL CEPHALOSPORIN [J].
UTSUI, Y ;
INOUE, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1085-1092
[10]  
1990, APPROVED STANDARDS M